Purpose: We aimed to investigate the incidence and clinical significance of incidental focal nasopharyngeal uptake on [F]FDG PET/CT and to evaluate the diagnostic performance of various metabolic parameters to differentiate between benign and malignant nasopharyngeal lesions.
Methods: A total of 63 consecutive patients with incidental focal nasopharyngeal uptake on [F]FDG PET/CT and subsequent nasopharyngeal biopsy were retrospectively enrolled. In addition, baseline pretherapeutic [F]FDG PET/CT images of 59 patients with newly diagnosed pathologically proven nasopharyngeal carcinoma (NPC) were reviewed. Maximum standardized uptake value (SUVmax), mean SUV (SUVmean), nasopharynx-to-palatine tonsil ratio (NPR), metabolic tumor volume (MTV), and total lesion glycolysis (TLG) of the nasopharyngeal lesions were determined. Receiver operating characteristic (ROC) curve analysis was used to evaluate the diagnostic performance of the metabolic parameters.
Results: Incidental focal nasopharyngeal uptake in two patients (3.2%, 2/63) was pathologically confirmed to be NPC. All the metabolic parameters (SUVmax, SUVmean, NPR, MTV, and TLG) demonstrated significantly greater values in patients with NPC compared with patients with benign or physiological nasopharyngeal uptake ( < 0.001). Among the metabolic parameters, NPR demonstrated the greatest area under the curve of 0.992 ( < 0.05), with a sensitivity of 96.7% and a specificity of 93.4% when a cut-off of 1.1 was used. Similar results were seen in nasopharyngeal lesions without morphological abnormality.
Conclusion: NPC is an infrequent but important cause of incidental focal nasopharyngeal uptake on [F]FDG PET/CT. Metabolic parameters were shown to be useful to differentiate between benign and malignant nasopharyngeal lesions, and NPR showed the best diagnostic performance.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679055 | PMC |
http://dx.doi.org/10.1007/s13139-022-00771-5 | DOI Listing |
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
January 2025
To explore the hypothesis of "pathogen storage pool" by analyzing the local microbial community of adenoids. Under the guidance of a 70° nasal endoscope, sterile swabs were used to collect secretions from the adenoid crypts of the subjects. The samples were sent to the laboratory for DNA extraction and standard bacterial 16S full-length sequencing analysis.
View Article and Find Full Text PDFInt J Surg Case Rep
December 2024
Department of Internal medicine, Hawassa University Comprehensive Specialized Hospital, Hawassa, Sidama, Ethiopia.
Introduction And Importance: Chordoma is an uncommon malignant tumor that originates from the remnants of the primitive notochord in the embryo. They account for 1 % of intracranial tumors and 4 % of primary bone tumors. It is a locally aggressive tumor with a low risk of metastasis.
View Article and Find Full Text PDFNan Fang Yi Ke Da Xue Xue Bao
December 2024
School of Biomedical Engineering, Southern Medical University, Guangzhou 510515, China.
Vaccine
December 2024
Department of Epidemiology, Epiconcept, Paris, France.
Introduction: Repeated COVID-19 booster vaccination was recommended in healthcare workers (HCWs) to maintain protection. We measured the relative vaccine effectiveness (rVE) of the second booster dose of COVID-19 vaccine compared to the first booster, against laboratory-confirmed SARS-CoV-2 infection in HCWs.
Methods: In a prospective cohort study among HCWs from 12 European hospitals, we collected nasopharyngeal or saliva samples at enrolment and during weekly/fortnightly follow-up between October 2022 and May 2023.
Laryngoscope
December 2024
Division of Rhinology, Department of Otolaryngology, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan.
Objective: Post-irradiation sinonasal mucosa disease (SMD) is observed in patients with nasopharyngeal carcinoma (NPC) treated with radiotherapy (RT), leading to a detrimental impact on quality of life. This study aimed to assess the incidence, severity, and regression of the post-irradiation SMD among patients with NPC treated with proton therapy.
Methods: NPC patients treated with proton therapy were retrospectively enrolled.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!